Discovery of Novel Benzothiazole-Based PDE4 Inhibitors for Central Nervous System Disorders.

This patent describes compounds and pharmaceutical compositions thereof for inhibiting PDE4 and treatment of disease.

ACS Medicinal Chemistry Letters 2026;17(5):994–995. DOI: 10.1021/acsmedchemlett.6c00099